Search research articles
Contact Us
Filters
Showing results (61-70 of 310) with videos related to
Page
of 31
Sort By:
Alzheimer'S Research & Therapy
|
June 13, 2022
Correction: Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217
Colin Groot, Claudia Cicognola, Divya Bali, et al.
Neurology
|
May 14, 2026
The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive Decline
María Rivera Sánchez, Sophie E Mastenbroek, Shorena Janelidze, et al.
Brain : a Journal of Neurology
|
December 6, 2020
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease
Joana B Pereira, Shorena Janelidze, Rik Ossenkoppele, et al.
Journal of Alzheimer'S Disease : JAD
|
April 8, 2014
Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort
Marissa Zwan, Argonde van Harten, Rik Ossenkoppele, et al.
Alzheimer'S Research & Therapy
|
May 15, 2022
Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217
Colin Groot, Claudia Cicognola, Divya Bali, et al.
Neurology
|
July 4, 2019
Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship
Anna Catharina van Loenhoud, Wiesje Maria van der Flier, Alle Meije Wink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 14, 2013
Longitudinal amyloid imaging using 11C-PiB: methodologic considerations
Bart N M van Berckel, Rik Ossenkoppele, Nelleke Tolboom, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 31, 2026
Bayesian modelling demonstrates clinically relevant heterogeneity in Tau PET patterns in Alzheimer's disease
Ye Xia, Keith Johnson, Georges El Fakhri, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society
|
July 11, 2022
The recognition and management of neuropsychiatric symptoms in early Alzheimer's disease: a qualitative study among Dutch memory clinic physicians
Willem S Eikelboom, Najoua Lazaar, Rozemarijn L van Bruchem-Visser, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 1, 2026
Tau in Alzheimer's disease: Shaping the future patient journey
Catherine J Mummery, Christopher Chen Li-Hsian, Cristian A Lasagna-Reeves, et al.
Page
of 31
Search research articles
Search
Showing results (61-70 of 310) with videos related to
Sort By:
Page
of 31
Alzheimer'S Research & Therapy
|
June 13, 2022
Correction: Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217
Colin Groot, Claudia Cicognola, Divya Bali, et al.
Neurology
|
May 14, 2026
The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive Decline
María Rivera Sánchez, Sophie E Mastenbroek, Shorena Janelidze, et al.
Brain : a Journal of Neurology
|
December 6, 2020
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease
Joana B Pereira, Shorena Janelidze, Rik Ossenkoppele, et al.
Journal of Alzheimer'S Disease : JAD
|
April 8, 2014
Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort
Marissa Zwan, Argonde van Harten, Rik Ossenkoppele, et al.
Alzheimer'S Research & Therapy
|
May 15, 2022
Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217
Colin Groot, Claudia Cicognola, Divya Bali, et al.
Neurology
|
July 4, 2019
Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship
Anna Catharina van Loenhoud, Wiesje Maria van der Flier, Alle Meije Wink, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 14, 2013
Longitudinal amyloid imaging using 11C-PiB: methodologic considerations
Bart N M van Berckel, Rik Ossenkoppele, Nelleke Tolboom, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 31, 2026
Bayesian modelling demonstrates clinically relevant heterogeneity in Tau PET patterns in Alzheimer's disease
Ye Xia, Keith Johnson, Georges El Fakhri, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society
|
July 11, 2022
The recognition and management of neuropsychiatric symptoms in early Alzheimer's disease: a qualitative study among Dutch memory clinic physicians
Willem S Eikelboom, Najoua Lazaar, Rozemarijn L van Bruchem-Visser, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 1, 2026
Tau in Alzheimer's disease: Shaping the future patient journey
Catherine J Mummery, Christopher Chen Li-Hsian, Cristian A Lasagna-Reeves, et al.
Page
of 31